急性ST段抬高型心肌梗死患者甲状腺激素水平变化及临床意义被引量：1

下载PDF

导出

摘要目的评价ST段抬高型急性心肌梗死(AMI)患者血清甲状腺激素水平变化的临床意义。方法以我院心内科住院急性ST抬高型心肌梗死患者52例为AMI组,陈旧性心肌梗死(OMI)患者48例作为对照组。两组患者空腹取静脉血5 m L,采用全自动微粒子化学发光分析仪定量检测甲状腺激素。结果与对照组相比,AMI组血清游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)明显下降,差异有统计学意义(P<0.05)。结论血清FT3、FT4水平可反映急性ST段抬高型心肌梗死病情及冠脉血管病变的严重程度,病情越严重,下降越明显。

作者沈俊袁双双陈小林刘星

机构地区湖北省宜昌市夷陵医院

出处《中西医结合心脑血管病杂志》 2015年第14期1655-1656,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease

关键词急性ST段抬高型心肌梗死陈旧性心肌梗死甲状腺激素

分类号 R542.22 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献7

1Rodrigo CP,Gilbert.PC,Claudia CE,et al. Thyroid hormoneprofile in acute coronary syndromes[J].Cardiol,2006,87C6) :78 - 80.
2Vita JA,Gokce N, Duffy SJ, et al. Effect of atorvastatin on endo-thelium -dependent vasodilation in patients with coronary arterydisease[J]. Am J Cardiol, 2CXJ3,91(7): 857 - 860.
3Celermajer DS,Sorensen KE, Gooch VM, ef al. Non - invasivedetection of endothelial dysfunction in children and adults at riskof atherosclerosis[J]. Lancet, 1992,340(8828) : 1111 - 1115.
4Klein L, Danzi S.Thyroid disease and the heart[J].Circulation.2007,116:1725-1735.
5齐欣,孙跃民,万征,杨振文,胡越成.急性冠脉综合征患者血清甲状腺激素变化及意义[J].中国慢性病预防与控制,2010,18(1):52-54. 被引量：13
6Friberg L,Wemer S-Eggertsen G,et al .Rapid down - regulationof thyroid hormones in acute myocardial infarction: Is it cardio-protective in patients with angina[J].Arch Intern Med,2002. 162(12):1388-1394.
7Friberg L,Drvota V,Bjelak AH’ ef al .Association between in-creased levels of reverse triiodothyronine and mortality after a-cute myocardial infarction[J].Am J Med, 2001,111 (9) :699 - 703.

二级参考文献13

1黄家胜.急性心肌梗死治疗前后甲状腺激素变化与心功能的关系[J].实用全科医学,2006,4(5):517-518. 被引量：5
2lelwasi G,Pingitore A,Landi P,et al.Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease [J]. Circulation, 2003,108:708-713.
3Rodrigo CP,Gilberto PC,Claudia CE,et al.Thyroid hormone profile in acute cornary syndromes[J].Arq Bras Cardiol,2006,87:688-694.
4Lee WY,Suh JY,Kim SW,et al.Circulating IL-8 and IL-10 in euthyroid sick syndromes following bone marrow transplantation [J].Korean Med Sci,2002,17:755 -760.
5徐桂波.急性心肌梗死患者血清甲状腺激素变化及意义.临床心血管病杂志,2004,16(4):153-153.
6Mulvihill NT Foley B,Murphy R,et al.Evidenee of prolonged inflammation in unstable angina and non-Q wave myocardial infarction [J].JACC,2000,36: 1210-1216.
7Mueller C,Buetter HJ,Hodgson JM,et al.Inflammatory and long-term mortality after non-ST-elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients[J.]. Circulation, 2002, 105: 1412-1415.
8Chew DP, Bhatt DL, Robbins MA ,et al.Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention [J].Circulation,2001,104: 992- 997.
9Nagaya T, Fujioda M,Otsuka G,et al.A potentia; role of activated NFKB in the pathogenesis of enthyroid sick syndrome[J].Clin Invest , 2000,106:393-402.
10Verma S,Li SH,Badiwala MV,et al.Endothelin antagonism and inter-leukin-6 inhibition attenuate the proatherogenie effects of C-reactive protein[J]. Circulation,2002,105:1890-1896.